Brian Pettitt-Schieber1, Ching Siong Tey2, Robert Hill3, William Vaughn3, Vivek Pakanati4, Roberta Leu2, Nikhila Raol5. 1. School of Medicine, Emory University, Atlanta, GA, USA. 2. School of Medicine, Department of Pediatrics, Emory University, Atlanta, GA, USA. 3. School of Medicine, Mercer University, Atlanta, GA, USA. 4. School of Medicine, Saba University, The Bottom, Saba, Caribbean Netherlands, Netherlands. 5. School of Medicine, Department of Otolaryngology-Head and Neck Surgery, Emory University, 2015 Uppergate Drive, Atlanta, GA, 30322, USA. nikhila.p.raol@emory.edu.
Abstract
PURPOSE: The purpose of this study was to determine the associations between cardiac function and postoperative adverse events in pediatric patients with obstructive sleep apnea (OSA). METHODS: Patients between birth and 18 years of age diagnosed with OSA between January 1, 2015, and December 31, 2018, who underwent echocardiographic evaluation within 6 months of surgery at a tertiary care children's hospital were evaluated. Exclusion criteria included history of neuromuscular disorders, tracheostomy placement, or a predominance of central apneic events recorded during polysomnography (PSG). Patients were grouped by OSA severity. Chi-squared analysis and logistic regression were utilized to determine associations between demographic characteristics, OSA severity, preoperative echocardiographic abnormalities, and postoperative adverse events. RESULTS: One hundred ten children met inclusion criteria for the study, including 22 with mild OSA, 22 with moderate OSA, and 66 with severe OSA. Race and the presence of congenital heart disease (CHD) were significantly associated with differences in OSA severity. Echocardiographic abnormalities were found in 45 patients, but exclusion of patients with CHD revealed no significant associations with differences in OSA severity. Postoperative adverse events were identified in 18 (16%) patients, and only O2 saturation nadir was found to be a significant predictor of these complications. CONCLUSION: Preoperative echocardiogram abnormalities are not commonly found in children with OSA and presence of abnormalities does not predict postoperative adverse events. O2 saturation nadir measured on preoperative PSG is a significant predictor of postoperative adverse events and should be examined as a clinical indicator of OSA severity.
PURPOSE: The purpose of this study was to determine the associations between cardiac function and postoperative adverse events in pediatric patients with obstructive sleep apnea (OSA). METHODS: Patients between birth and 18 years of age diagnosed with OSA between January 1, 2015, and December 31, 2018, who underwent echocardiographic evaluation within 6 months of surgery at a tertiary care children's hospital were evaluated. Exclusion criteria included history of neuromuscular disorders, tracheostomy placement, or a predominance of central apneic events recorded during polysomnography (PSG). Patients were grouped by OSA severity. Chi-squared analysis and logistic regression were utilized to determine associations between demographic characteristics, OSA severity, preoperative echocardiographic abnormalities, and postoperative adverse events. RESULTS: One hundred ten children met inclusion criteria for the study, including 22 with mild OSA, 22 with moderate OSA, and 66 with severe OSA. Race and the presence of congenital heart disease (CHD) were significantly associated with differences in OSA severity. Echocardiographic abnormalities were found in 45 patients, but exclusion of patients with CHD revealed no significant associations with differences in OSA severity. Postoperative adverse events were identified in 18 (16%) patients, and only O2 saturation nadir was found to be a significant predictor of these complications. CONCLUSION: Preoperative echocardiogram abnormalities are not commonly found in children with OSA and presence of abnormalities does not predict postoperative adverse events. O2 saturation nadir measured on preoperative PSG is a significant predictor of postoperative adverse events and should be examined as a clinical indicator of OSA severity.
Authors: Raouf S Amin; Thomas R Kimball; Maninder Kalra; Jenny L Jeffries; John L Carroll; Judy A Bean; Sandra A Witt; Betty J Glascock; Stephen R Daniels Journal: Am J Cardiol Date: 2005-03-15 Impact factor: 2.778
Authors: Michael E McCormick; Anthony Sheyn; Michael Haupert; Ronald Thomas; Adam J Folbe Journal: Int J Pediatr Otorhinolaryngol Date: 2011-09-01 Impact factor: 1.675
Authors: Antoinette T Burns; Shana L Hansen; Zachary S Turner; James K Aden; Alexander B Black; Daniel P Hsu Journal: J Clin Sleep Med Date: 2019-08-15 Impact factor: 4.062
Authors: Peter C Revenaugh; Lauren J Chmielewski; Thomas Edwards; Jyoti Krishna; Paul Krakovitz; Samantha Anne Journal: Arch Otolaryngol Head Neck Surg Date: 2011-12
Authors: Ron B Mitchell; Sanford M Archer; Stacey L Ishman; Richard M Rosenfeld; Sarah Coles; Sandra A Finestone; Norman R Friedman; Terri Giordano; Douglas M Hildrew; Tae W Kim; Robin M Lloyd; Sanjay R Parikh; Stanford T Shulman; David L Walner; Sandra A Walsh; Lorraine C Nnacheta Journal: Otolaryngol Head Neck Surg Date: 2019-02 Impact factor: 3.497
Authors: Raouf S Amin; Thomas R Kimball; Judy A Bean; Jenny L Jeffries; J Paul Willging; Robin T Cotton; Sandra A Witt; Betty J Glascock; Steven R Daniels Journal: Am J Respir Crit Care Med Date: 2002-05-15 Impact factor: 21.405
Authors: Maninder Kalra; Thomas R Kimball; Stephen R Daniels; Grace LeMasters; Paul J Willging; Michael Rutter; Sandra A Witt; Betty J Glascock; Raouf S Amin Journal: Sleep Med Date: 2004-12-10 Impact factor: 3.492
Authors: Melissa A Maloney; Sally L Davidson Ward; Jennifer A Su; Ramon A Durazo-Arvizu; Jacqueline M Breunig; Daniel U Okpara; Emily S Gillett Journal: J Clin Sleep Med Date: 2022-06-01 Impact factor: 4.324